Paper36988742
Combined targeted and untargeted high-resolution mass spectrometry analyses to investigate metabolic alterations in pompe disease.
de Moraes MBM and 5 others. Metabolomics, 2023. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Combined targeted and untargeted high-resolution mass spectrometry analyses to investigate metabolic alterations in pompe disease. Papers, record 36988742. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36988742
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Combined targeted and untargeted high-resolution mass spectrometry analyses to investigate metabolic alterations in pompe disease.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glycogen Storage Disease Type II | Major topic |
| Humans | |
| Metabolomics | |
| Biomarkers | |
| Phenotype | |
| Tandem Mass Spectrometry |
Source PubMed
References58
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33260301 | The Release of a Soluble Glycosylated Protein from Glycogen by Recombinant Lysosomal α-Glucosidase (rhGAA) In Vitro and Its Presence in Serum In Vivo. | Biomolecules | 2020 | https://conductscience.org/library/papers/33260301 | PubMed |
| 2 | 31101460 | Severe distal muscle involvement and mild sensory neuropathy in a boy with infantile onset Pompe disease treated with enzyme replacement therapy for 6 years. | Neuromuscul Disord | 2019 | https://conductscience.org/library/papers/31101460 | PubMed |
| 3 | 29095812 | Moonlighting newborn screening markers: the incidental discovery of a second-tier test for Pompe disease. | Genet Med | 2018 | https://conductscience.org/library/papers/29095812 | PubMed |
| 4 | 7808465 | Creatine metabolism and the consequences of creatine depletion in muscle. | Mol Cell Biochem | 1994 | https://conductscience.org/library/papers/7808465 | PubMed |
| 5 | 13692569 | Determination of creatinine by means of automatic chemical analysis. | Tech Bull Regist Med Technol | 1960 | https://conductscience.org/library/papers/13692569 | PubMed |
| 6 | 21423183 | Metabolite profiles and the risk of developing diabetes. | Nat Med | 2011 | https://conductscience.org/library/papers/21423183 | PubMed |
| 7 | 36029375 | Quality assurance and quality control reporting in untargeted metabolic phenotyping: mQACC recommendations for analytical quality management. | Metabolomics | 2022 | https://conductscience.org/library/papers/36029375 | PubMed |
| 8 | 32523032 | Clinical Validation of Targeted and Untargeted Metabolomics Testing for Genetic Disorders: A 3 Year Comparative Study. | Sci Rep | 2020 | https://conductscience.org/library/papers/32523032 | PubMed |
| 9 | 25938372 | MS-DIAL: data-independent MS/MS deconvolution for comprehensive metabolome analysis. | Nat Methods | 2015 | https://conductscience.org/library/papers/25938372 | PubMed |
| 10 | 6686838 | Effect of experimental hyperphenylalaninemia on myelin metabolism at later stages of brain development. | Int J Neurosci | 1983 | https://conductscience.org/library/papers/6686838 | PubMed |
| 11 | 24039616 | Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI). | Metabolomics | 2007 | https://conductscience.org/library/papers/24039616 | PubMed |
| 12 | 15292070 | Direct multiplex assay of lysosomal enzymes in dried blood spots for newborn screening. | Clin Chem | 2004 | https://conductscience.org/library/papers/15292070 | PubMed |
| 13 | 15784740 | Defective N-acetylaspartate catabolism reduces brain acetate levels and myelin lipid synthesis in Canavan's disease. | Proc Natl Acad Sci U S A | 2005 | https://conductscience.org/library/papers/15784740 | PubMed |
| 14 | 24421768 | N-Acetylaspartate reductions in brain injury: impact on post-injury neuroenergetics, lipid synthesis, and protein acetylation. | Front Neuroenergetics | 2013 | https://conductscience.org/library/papers/24421768 | PubMed |
| 15 | 27419259 | Hydrogen Rearrangement Rules: Computational MS/MS Fragmentation and Structure Elucidation Using MS-FINDER Software. | Anal Chem | 2016 | https://conductscience.org/library/papers/27419259 | PubMed |
| 16 | 21687968 | Urine analysis of glucose tetrasaccharide by HPLC; a useful marker for the investigation of patients with Pompe and other glycogen storage diseases. | J Inherit Metab Dis | 2012 | https://conductscience.org/library/papers/21687968 | PubMed |
| 17 | 32382504 | Urine glucose tetrasaccharide: A good biomarker for glycogenoses type II and III? A study of the French cohort. | Mol Genet Metab Rep | 2020 | https://conductscience.org/library/papers/32382504 | PubMed |
| 18 | 16857770 | Brain development in infantile-onset Pompe disease treated by enzyme replacement therapy. | Pediatr Res | 2006 | https://conductscience.org/library/papers/16857770 | PubMed |
| 19 | 34251446 | Comparison of Untargeted Metabolomic Profiling vs Traditional Metabolic Screening to Identify Inborn Errors of Metabolism. | JAMA Netw Open | 2021 | https://conductscience.org/library/papers/34251446 | PubMed |
| 20 | 23632029 | Pompe disease: early diagnosis and early treatment make a difference. | Pediatr Neonatol | 2013 | https://conductscience.org/library/papers/23632029 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42506432 | Metabolomic Insights into Lysosomal Storage Diseases: An Untargeted View. | Metabolites | 2026 | https://conductscience.org/library/papers/42506432 | PubMed |
| 41695778 | Pompe disease: a country-wide molecular screening in a cohort of 15,068 study participants. | Front Mol Biosci | 2025 | https://conductscience.org/library/papers/41695778 | PubMed |
| 41282336 | A multi-omics-empowered framework for precision diagnosis and treatment of lysosomal diseases. | J Pharm Anal | 2025 | https://conductscience.org/library/papers/41282336 | PubMed |
| 41103296 | Metabolomic profiling reveals novel biomarkers and therapeutic targets in Legg-Calvé-Perthes disease: a comprehensive analysis of peripheral blood and endothelial function. | Front Physiol | 2025 | https://conductscience.org/library/papers/41103296 | PubMed |
| 37759559 | Omics-Based Approaches for the Characterization of Pompe Disease Metabolic Phenotypes. | Biology (Basel) | 2023 | https://conductscience.org/library/papers/37759559 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| SI | 6476 | PubTator's text mining | https://conductscience.org/library/genes/6476 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36988742
GET https://conductscience.org/api/papers/v1/36988742/references?page=2